Entrada Therapeutics GAAP EPS of -$0.29 beats by $0.81, revenue of $41.85M
Entrada Therapeutics GAAP EPS of -$0.29 beats by $0.81, revenue of $41.85M
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
-
Stoke Therapeutics GAAP EPS of -$0.60 beats by $0.02, revenue of $2.8M misses by $0.42M
SeekingAlpha
-
Aligos Therapeutics GAAP EPS of -$0.22 beats by $0.05, revenue of $2.68M beats by $1.08M
SeekingAlpha
-
BioXcel Therapeutics GAAP EPS of -$0.76 beats by $0.15, revenue of $0.38M misses by $0.36M
SeekingAlpha
-
Janux Therapeutics GAAP EPS of -$0.25 beats by $0.16, revenue of $2.46M beats by $1.72M
SeekingAlpha